Literature DB >> 18472013

Purification, characterization and bactericidal activities of basic phospholipase A2 from the venom of Agkistrodon halys (Chinese pallas).

R Perumal Samy1, P Gopalakrishnakone, Bow Ho, Vincent T K Chow.   

Abstract

Agkistrodon snake venoms contain a variety of phospholipases (PLA2), some of which are myotoxic. In this study, we used reverse-phase HPLC to purify PLA2 from the venom of Agkistrodon halys. The enzyme named as AgkTx-II, a basic Asp49 PLA2, has a molecular masses of 13,869.05. The amino acid sequence and molecular mass of AgkTx-II was identical to those of an Asp49 basic myotoxic PLA2 previously isolated from this venom. Antibacterial activities were tested by susceptibility and broth-dilution assays. AgkTx-II exerted a potent antibacterial activity against Staphylococcus aureus, Proteus vulgaris, Proteus mirabilis, and Burkholderia pseudomallei. The MIC values of AgkTx-II ranged between 85 and 2.76microM and was most effective against S. aureus, P. vulgaris, P. mirabilis (MIC of 21.25microM) and B. pseudomallei (MIC of 10.25microM). This AgkTx-II rapidly killed S. aureus, P. vulgaris and B. pseudomallei in a dose-dependent manner. The effect of the AgkTx-II on bacterial membranes was evaluated by scanning and transmission electron microscopy. AgkTx-II caused morphological alterations apparent on their cellular surfaces, suggesting a killing mechanism based on membrane permeabilization and damage. Cytotoxicity was measured by XTT tetrazolium (2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide) and lactate dehydrogenase (LDH) assays using U-937 cells (monocytes). The AgkTx-II did not affect cell viability up to 500microM concentrations but cell death was evident at 1000microM concentration after 24 and 48h. Furthermore, the repeated exposure of AgkTx-II (2-14microM) treated mice showed different tissue alterations, mainly at the brain and kidney; the toxicological potential of AgkTx-II remains to be elucidated. The AgkTx-II exhibits no hemolytic action even at high doses (10-100microM) in human erythrocytes. However, the AgkTx-II is believed to exert its bactericidal effect by permeabilizing the bacterial membrane by forming pores. In addition, the basic PLA2 AgkTx-II displays a bactericidal effect, which may be either dependent or independent of catalysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472013     DOI: 10.1016/j.biochi.2008.04.007

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  Cobra cytotoxins: structural organization and antibacterial activity.

Authors:  P V Dubovskii; Y N Utkin
Journal:  Acta Naturae       Date:  2014-07       Impact factor: 1.845

2.  Antibacterial Activity of Isolated Immunodominant Proteins of Naja Naja (Oxiana) Venom.

Authors:  Mahboobeh Talebi Mehrdar; Rasool Madani; Reza Hajihosseini; Soheila Moradi Bidhendi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 3.  Antimicrobials from Venomous Animals: An Overview.

Authors:  Tania Yacoub; Mohamad Rima; Marc Karam; Jean-Marc Sabatier And Ziad Fajloun
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

Review 4.  Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs.

Authors:  Clara Pérez-Peinado; Sira Defaus; David Andreu
Journal:  Toxins (Basel)       Date:  2020-04-15       Impact factor: 4.546

5.  Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells.

Authors:  Mari Samel; Heiki Vija; Imbi Kurvet; Kai Künnis-Beres; Katrin Trummal; Juhan Subbi; Anne Kahru; Jüri Siigur
Journal:  Toxins (Basel)       Date:  2013-01-24       Impact factor: 4.546

6.  Assessment of the Antimicrobial Activity of Few Saudi Arabian Snake Venoms.

Authors:  Abdulrahman K Al-Asmari; Rajamohamed Abbasmanthiri; Nasreddien M Abdo Osman; Yunus Siddiqui; Faisal Ahmed Al-Bannah; Abdulgadir M Al-Rawi; Sarah A Al-Asmari
Journal:  Open Microbiol J       Date:  2015-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.